학술논문

Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial
Document Type
Article
Source
In The Lancet Oncology November 2016 17(11):1579-1589
Subject
Primary Research
Articles
Language
ISSN
1470-2045